MedPath

Cognitive Behavior Therapy for Patients With Psychoses.

Not Applicable
Completed
Conditions
Schizophrenia Spectrum and Other Psychotic Disorders
Interventions
Behavioral: Cognitive Behavior Therapy
Behavioral: Acceptance and Commitment Therapy
Registration Number
NCT03501888
Lead Sponsor
Karolinska Institutet
Brief Summary

Patients with psychoses are randomized either to group treatment (ACT) or individual CBT for 18 sessions.

Detailed Description

Since patients in the early stage of the illness seem to benefit more from CBT than patients with chronic conditions the present research will focus on patients with psychosis at the early stages of their illness. Patients with first episode psychosis from the Northern Stockholm Psychiatry (Midhagen) and the South West Stockholm Psychiatry (TIPS) will be included.

Scores on Alcohol Use disorder identification Test (AUDIT) and Drug Use disorder Identification Test (DUDIT) will be used as a covariate in order to control for the patients' s drug and alcohol use habits.

The study is single blind randomized controlled trials of manualized Cognitive Behavior Group Therapy (CBGT) versus an active treatment condition of individual CBT for patients with first episode psychosis. A total of 16 patients are enrolled and randomly allocated to either CBGT or to individual CBT treatment. Then 18 structured CBGT or individual CBT sessions approximately once a week will be offered. Three experienced CBT trained therapists will perform the therapies. Two therapists will be allocated to each group composed by approximately 5 patients.

The group therapies are conducted according to the Acceptance and Commitment Therapy (ACT) for psychosis manual (an 18 Session Group Therapy Protocol by Pearson A. \& Tingey R.). The individual therapies are conducted according to non-manualized ordinary clinical procedure. The ACT manual is originally constructed for patients with chronic schizophrenia and has therefore been adapted by the therapists to be appropriate for patients with first episode psychosis. The therapists have taken a course in ACT and they receive ACT-supervision during the trial.

Assessments in both studies will be carried out at baseline, after therapy completion and 6 months later by an independent rater blind to group allocation and not involved in the treatment of the patients. The raters blindness will be measured.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
16
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • Patients with drug abuse diagnosis
  • organic brain injury,
  • patients with grave somatic illness with secondary psychotic symptoms.
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Cognitive Behavior Therapy (CBT)Cognitive Behavior TherapyCBT: individually, ca 18 weeks.
Acceptance and Commitment Therapy (ACT)Acceptance and Commitment TherapyACT: given in a group setting: ca 18 weeks.
Primary Outcome Measures
NameTimeMethod
Symptoms of psychosesUp to 11 months

measured with PANSS (subscales: positive and negative symptoms).

Secondary Outcome Measures
NameTimeMethod
Drug useUp to 11 months

Drug Use Disorder Identification Test.

Quality of Life,Up to 11 months

Quality of life is measured by Brunnsviken Brief Quality of Life Inventory.

Self EsteemUp to 11 months

Self esteem is measured by Self Concept Questionaire

Psychological inflexibility and Experiential Avoidance.Up to 11 months

Psychological inflexibility and experiential avoidance is measured with Acceptance and Action Questionaire II

Symptoms of anxietyUp to 11 months

Becks Anxiety Inventory,

Alcohol useUpt to 11 months

Alcohol Use Disorder Identification Test

Symptoms of depressionUp to 11 months

Symptoms of Depression; Becks Depression Inventory.

Values,Up to 11 months

Living in accordance with ones values is measured by Bull´s eye Values Survey.

Treatment safetyUp to 11 months

Treatment safety is evaluated through assessment of adverse effects or events by registering suicide, suicide attempts, re-hospitalization and severe depressive symptom exacerbation).

© Copyright 2025. All Rights Reserved by MedPath